Efficacy of duloxetine vs. placebo in mild, moderate, and more severely ill patients with major depressive disorder

被引：0
|
作者：
Prakash, A.
Pons, A.
Shelton, R.
Mallinckrodt, C.
Robinson, M.
Wohlreich, M.
Raskin, J.
Detke, M.
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Vanderbilt Univ, Sch Med, Nashville, TN USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [1] Duloxetine vs. placebo in the prevention of relapse of major depressive disorder
    Detke, MJ
    Gilaberte, I
    Perahia, DG
    Wang, F
    Lee, TC
    Tran, PV
    Miner, CM
    Montgomery, SA
    [J]. EUROPEAN PSYCHIATRY, 2004, 19 : 214S - 214S
  • [2] The safety and tolerability of duloxetine vs. placebo in the treatment of elderly patients with major depressive disorder (MDD)
    Raskin, J
    Wiltse, C
    Dinkel, J
    Xu, J
    Katona, C
    Gandhi, P
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A47 - A47
  • [3] Duloxetine vs placebo in the prevention of relapse of major depressive disorder
    Detke, M
    Gilaberte, I
    Perahia, D
    Wang, F
    McNamara, R
    Tran, P
    Miner, C
    Montgomery, SA
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S261 - S262
  • [4] Duloxetine vs placebo in the prevention of relapse of Major Depressive Disorder
    Detke, MJ
    Gilaberte, I
    Perahia, DG
    Clemens, JW
    Tran, PV
    Miner, C
    Montgomery, S
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S175 - S175
  • [5] CLINICAL EFFICACY AND SAFETY OF DULOXETINE IN COMPARISON WITH PLACEBO IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN POLAND
    Pankiewicz, O.
    Jagodzinska, K.
    Rys, P.
    Lach, K.
    Jarczewska, D.
    Cel, M.
    Mierzejewski, P.
    Bartminski, W.
    Plisko, R.
    Wladysiuk, M.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A351 - A351
  • [6] EFFICACY OF DULOXETINE ON FUNCTIONAL IMPAIRMENT IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Sheehan, David V.
    Meyers, Adam L.
    Ahl, Jonna
    Prakash, Apurva
    Oakes, Tina Marie Myers
    Kelin, Katarina
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2011, 45 : A63 - A63
  • [7] Duloxetine efficacy for major depressive disorder in male vs. female patients: Data from 7 randomized, double-blind, placebo-controlled trials
    Kornstein, Susan G.
    Wohlreich, Madelaine M.
    Mallinckrodt, Craig H.
    Watkin, John G.
    Stewart, Donna E.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (05) : 761 - 770
  • [8] Efficacy of agomelatine in elderly patients with major depressive disorder (MDD). Arandomised, double-blind study vs. placebo
    Heun, R.
    Corral, R. M.
    Ahokas, A.
    Nicolini, H.
    Teixeira, J. M.
    Dehelean, P.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 147 - 148
  • [9] Efficacy of duloxetine in painful symptoms with major depressive disorder
    Castano, J.
    Garnier, C.
    Corcoles, D.
    Rodriguez, L.
    Diaz, B.
    Martin, L. M.
    Bulbena, A.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S298 - S299
  • [10] Duloxetine for the treatment of major depressive disorder in patients age ≥ 55, 1:: Efficacy
    Kennedy, JS
    Mallinckrodt, CH
    Tran, PV
    Wohlreich, MM
    Detke, MJ
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) : 1068 - 1069
12345